Servier Pharmaceuticals (India) Private Limited, a active private limited company, was established on 28 September 1998 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51397MH1998PTC116694. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.77 M.
It upholds a compliant status. Its leadership includes Bradley Ryan Lloyd (Additional Director), Pierre Jean Bernard Andriot (Director), Aurelien Breton (Director). Past directors included Jan Frederic Paul Kesselhut, Pierre Perez, Jean Luc Jacques Gaston Thomas. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 17Th Floor, Crescenzo Business District, B Wing, Plot Nos C-38 & C-39,, G Block, Behind Mca, Bkc, Bandra East,, Mumbai, Maharashtra, 400051.
U51397MH1998PTC116694
116694
28 September 1998
₹1.00 M
₹0.77 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Servier Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bradley Ryan Lloyd | Additional Director | 13 Jun 2025 | Current |
| Pierre Jean Bernard Andriot | Director | 18 Dec 2013 | Current |
| Aurelien Breton | Director | 23 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2014 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2020 | Past |
| Pramod Abcsdd | Director | 15 Jan 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2014 | Past |
| Pramod Abcsdd | Director | 26 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Servier Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 14.16% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Servier Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Servier Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Servier Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Servier Pharmaceuticals (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Servier Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Bradley Ryan Lloyd was appointed as a Additional Director was appointed as a Additional Director on 13 Jun 2025 & has been associated with this company since 6 months 5 days . was completed.
Progress on Servier Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on Aurelien Breton was appointed as a Director was appointed as a Director on 23 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
Progress on Pierre Jean Bernard Andriot was appointed as a Director was appointed as a Director on 18 Dec 2013 & has been associated with this company since 11 years 11 months . was documented.
The activity Servier Pharmaceuticals (India) Private Limited was registered on 28 Sep 1998 with Roc Mumbai & aged 27 years 2 months as per MCA records. was completed.
The CIN of Servier Pharmaceuticals (India) Private Limited is U51397MH1998PTC116694.
Servier Pharmaceuticals (India) Private Limited is headquartered at 17Th Floor, Crescenzo Business District, B Wing, Plot Nos C-38 & C-39,, G Block, Behind Mca, Bkc, Bandra East,, Mumbai, Maharashtra, 400051.
Servier Pharmaceuticals (India) Private Limited was incorporated on 28 September 1998.
The current directors of Servier Pharmaceuticals (India) Private Limited are
The primary industry of Servier Pharmaceuticals (India) Private Limited is Pharma.
Servier Pharmaceuticals (India) Private Limited is unlisted.
The authorized capital of Servier Pharmaceuticals (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.77 M.
The compliance status of Servier Pharmaceuticals (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX